Interferon-inducible protein 16: Insight into the interaction with tumor suppressor p53

Structure

Volumn 19, Issue 3, 2011, Pages 418-429

  Liao, Jack C C ^a,b   Lam, Robert ^a,c   Brazda, Vaclav ^d   Duan, Shili ^a,b   Ravichandran, Mani ^c   Ma, Justin ^a,b   Xiao, Ting ^c   Tempel, Wolfram ^c   Zuo, Xiaobing ^e   Wang, Yun Xing ^e   Chirgadze, Nickolay Y ^a,c   Arrowsmith, Cheryl H ^a,b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE OF BIOPHYSICS   (Czech Republic)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON INDUCIBLE PROTEIN 16; NUCLEAR PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DNA PROTEIN COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION;

BINDING SITES; CELL LINE, TUMOR; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DNA; DNA-BINDING PROTEINS; ESCHERICHIA COLI; HUMANS; INTERFERONS; MODELS, MOLECULAR; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952468076     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2010.12.015     Document Type: Article

References (55)

1. Aglipay, J.A., Lee, S.W., Okada, S., Fujiuchi, N., Ohtsuka, T., Kwak, J.C., Wang, Y., Johnstone, R.W., Deng, C., Qin, J., and Ouchi, T. (2003). A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene 22, 8931-8938. (Pubitemid 38021509)
2. Albrecht, M., Choubey, D., and Lengauer, T. (2005). The HIN domain of IFI-200 proteins consists of two OB folds. Biochem. Biophys. Res. Commun. 327, 679-687.
3. Anderson, M.E., Woelker, B., Reed, M., Wang, P., and Tegtmeyer, P. (1997). Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation. Mol. Cell. Biol. 17, 6255-6264.
4. Ayed, A., Mulder, F.A., Yi, G.S., Lu, Y., Kay, L.E., and Arrowsmith, C.H. (2001). Latent and active p53 are identical in conformation. Nat. Struct. Biol. 8, 756-760.
5. Bochkarev, A., Pfuetzner, R.A., Edwards, A.M., and Frappier, L. (1997). Structure of the single-stranded-DNA-binding domain of replication protein A bound to DNA. Nature 385, 176-181. (Pubitemid 27034221)
6. Bochkareva, E., Korolev, S., and Bochkarev, A. (2000). The role for zinc in replication protein A. J. Biol. Chem. 275, 27332-27338.
7. Bochkareva, E., Belegu, V., Korolev, S., and Bochkarev, A. (2001). Structure of the major single-stranded DNA-binding domain of replication protein A suggests a dynamic mechanism for DNA binding. EMBO J. 20, 612-618. (Pubitemid 32126996)
8. Bochkareva, E., Kaustov, L., Ayed, A., Yi, G.S., Lu, Y., Pineda-Lucena, A., Liao, J.C., Okorokov, A.L., Milner, J., Arrowsmith, C.H., and Bochkarev, A. (2005). Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc. Natl. Acad. Sci. USA 102, 15412-15417.
9. Brazda, V., Palecek, J., Pospisilova, S., Vojtesek, B., and Palecek, E. (2000). Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies. Biochem. Biophys. Res. Commun. 267, 934-939.
10. Brazda, V., Jagelska, E.B., Fojta, M., and Palecek, E. (2006). Searching for target sequences by p53 protein is influenced by DNA length. Biochem. Biophys. Res. Commun. 341, 470-477.
11. Buczek, P., and Horvath, M.P. (2006). Structural reorganization and the cooperative binding of single-stranded telomere DNA in Sterkiella nova. J. Biol. Chem. 281, 40124-40134.
12. Charron, C., Roy, H., Blaise, M., Giege, R., and Kern, D. (2003). Non-discriminating and discriminating aspartyl-tRNA synthetases differ in the anticodonbinding domain. EMBO J. 22, 1632-1643. (Pubitemid 36417411)
13. Choubey, D. (2000). P202: an interferon-inducible negative regulator of cell growth. J. Biol. Regul. Homeost. Agents 14, 187-192.
14. Classen, S., Ruggles, J.A., and Schultz, S.C. (2001). Crystal structure of the N-terminal domain of Oxytricha nova telomere end-binding protein alpha subunit both uncomplexed and complexed with telomeric ssDNA. J. Mol. Biol. 314, 1113-1125.
15. Dawson, M.J., and Trapani, J.A. (1996). HIN-200: a novel family of IFN-inducible nuclear proteins expressed in leukocytes. J. Leukoc. Biol. 60, 310-316.
16. Deng, X., Habel, J.E., Kabaleeswaran, V., Snell, E.H., Wold, M.S., and Borgstahl, G.E. (2007). Structure of the full-length human RPA14/32 complex gives insights into the mechanism of DNA binding and complex formation. J. Mol. Biol. 374, 865-876.
17. Ding, Y., Lee, J.F., Lu, H., Lee, M.H., and Yan, D.H. (2006). Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2. Mol. Cell. Biol. 26, 1979-1996.
18. Fernandes-Alnemri, T., Yu, J.W., Datta, P., Wu, J., and Alnemri, E.S. (2009). AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-513.
19. Fujiuchi, N., Aglipay, J.A., Ohtsuka, T., Maehara, N., Sahin, F., Su, G.H., Lee, S.W., and Ouchi, T. (2004). Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation. J. Biol. Chem. 279, 20339-20344.
20. Gariglio, M., Azzimonti, B., Pagano, M., Palestro, G., De Andrea, M., Valente, G., Voglino, G., Navino, L., and Landolfo, S. (2002). Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J. Interferon Cytokine Res. 22, 815-821. (Pubitemid 35034696)
21. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606. (Pubitemid 27357952)
22. Gupta, V.B., Indi, S.S., and Rao, K.S.J. (2008). Studies on the role of amino acid stereospecificity in amyloid beta aggregation. J. Mol. Neurosci. 34, 35-43.
23. Gutterman, J.U. (1994). Cytokine therapeutics: lessons from interferon alpha. Proc. Natl. Acad. Sci. USA 91, 1198-1205.
24. Hiller, S., Kohl, A., Fiorito, F., Herrmann, T., Wider, G., Tschopp, J., Grutter, M.G., and Wuthrich, K. (2003). NMR structure of the apoptosis- and inflammation-related NALP1 pyrin domain. Structure 11, 1199-1205. (Pubitemid 37214882)
25. Holm, L., and Sander, C. (1993). Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233, 123-138.
26. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., Latz, E., and Fitzgerald, K.A. (2009). AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518.
27. Hupp, T.R., Meek, D.W., Midgley, C.A., and Lane, D.P. (1992). Regulation of the specific DNA binding function of p53. Cell 71, 875-886.
28. Hupp, T.R., Sparks, A., and Lane, D.P. (1995). Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-245.
29. Jagelska, E.B., Brazda, V., Pecinka, P., Palecek, E., and Fojta, M. (2008). DNA topology influences p53 sequence-specific DNA binding through structural transitions within the target sites. Biochem. J. 412, 57-63. (Pubitemid 351678335)
30. Johnstone, R.W., Wei, W., Greenway, A., and Trapani, J.A. (2000). Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16. Oncogene 19, 6033-6042. (Pubitemid 32039377)
31. Kerr, I.D., Wadsworth, R.I., Cubeddu, L., Blankenfeldt, W., Naismith, J.H., and White, M.F. (2003). Insights into ssDNA recognition by the OB fold from a structural and thermodynamic study of Sulfolobus SSB protein. EMBO J. 22, 2561-2570.
32. Koul, D., Obeyesekere, N.U., Gutterman, J.U., Mills, G.B., and Choubey, D. (1998). p202 self-associates through a sequence conserved among the members of the 200-family proteins. FEBS Lett. 438, 21-24. (Pubitemid 28517828)
33. Krissinel, E., and Henrick, K. (2007). Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774-797.
34. Leclerc, E., Leclerc, L., and Marden, M.C. (1993). Asymmetry of calmodulin revealed by peptide binding. J. Fluoresc. 3, 45-49.
35. Liu, G., Xia, T., and Chen, X. (2003). The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein. J. Biol. Chem. 278, 17557-17565.
36. Ludlow, L.E., Johnstone, R.W., and Clarke, C.J. (2005). The HIN-200 family: more than interferon-inducible genes? Exp. Cell Res. 308, 1-17. (Pubitemid 40984758)
37. Mark, W.-Y., Liao, J.C.C., Lu, Y., Ayed, A., Laister, R., Szymczyna, B., Chakrabartty, A., and Arrowsmith, C.H. (2005). Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J. Mol. Biol. 345, 275-287.
38. Poterszman, A., Delarue, M., Thierry, J.C., and Moras, D. (1994). Synthesis and recognition of aspartyl-adenylate by Thermus thermophilus aspartyl-tRNA synthetase. J. Mol. Biol. 244, 158-167.
39. Prives, C., and Manley, J.L. (2001). Why is p53 acetylated? Cell 107, 815-818.
40. Raffaella, R., Gioia, D., De Andrea, M., Cappello, P., Giovarelli, M., Marconi, P., Manservigi, R., Gariglio, M., and Landolfo, S. (2004). The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells. Exp. Cell Res. 293, 331-345.
41. Roberts, T.L., Idris, A., Dunn, J.A., Kelly, G.M., Burnton, C.M., Hodgson, S., Hardy, L.L., Garceau, V., Sweet, M.J., Ross, I.L., et al. (2009). HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323, 1057-1060.
42. Sarkari, F., Sheng, Y., and Frappier, L. (2010). USP7/HAUSP promotes the sequence-specific DNA binding activity of p53. PLoS ONE 5, e13040.
43. Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., and Schreiber, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
44. Stehlik, C., and Reed, J.C. (2004). The PYRIN connection: novel players in innate immunity and inflammation. J. Exp. Med. 200, 551-558.
45. Theobald, D.L., and Schultz, S.C. (2003). Nucleotide shuffling and ssDNA recognition in Oxytricha nova telomere end-binding protein complexes. EMBO J. 22, 4314-4324. (Pubitemid 37021758)
46. Theobald, D.L., Mitton-Fry, R.M., and Wuttke, D.S. (2003). Nucleic acid recognition by OB-fold proteins. Annu. Rev. Biophys. Biomol. Struct. 32, 115-133.
47. Trapani, J.A., Browne, K.A., Dawson, M.J., Ramsay, R.G., Eddy, R.L., Show, T.B., White, P.C., and Dupont, B. (1992). A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics 36, 369-376.
48. Vogelstein, B., and Kinzler, K.W. (1992). p53 function and dysfunction. Cell 70, 523-526.
49. Wei, W., Clarke, C.J., Somers, G.R., Cresswell, K.S., Loveland, K.A., Trapani, J.A., and Johnstone, R.W. (2003). Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem. Cell Biol. 119, 45-54.
50. Weinberg, R.L., Freund, S.M., Veprintsev, D.B., Bycroft, M., and Fersht, A.R. (2004). J. Mol. Biol. 342, 801-811.
51. Xin, H., Pereira-Smith, O.M., and Choubey, D. (2004). Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 23, 6209-6217. (Pubitemid 39215291)
52. Xin, H., Curry, J., Johnstone, R.W., Nickoloff, B.J., and Choubey, D. (2003). Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene 22, 4831-4840. (Pubitemid 36981271)
53. Yan, H., Dalal, K., Hon, B.K., Youkharibache, P., Lau, D., and Pio, F. (2008). RPA nucleic acid-binding properties of IFI16-HIN200. Biochim. Biophys. Acta 1784, 1087-1097.
54. Yang, H., Jeffrey, P.D., Miller, J., Kinnucan, E., Sun, Y., Thoma, N.H., Zheng, N., Chen, P.L., Lee, W.H., and Pavletich, N.P. (2002). BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297, 1837-1848. (Pubitemid 35024337)
55. Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Bi, D., Weber, B.L., and El-Deiry, W.S. (1998). BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713-1721. (Pubitemid 28175052)